Header Logo

Connection

SHANNON RONCA to Vaccines, Subunit

Back to Details
This is a "connection" page, showing publications SHANNON RONCA has written about Vaccines, Subunit.
SHANNON RONCA
Connection Strength
0.095
Vaccines, Subunit
  1. Phase I interim results of a phase I/II study of the IgG-Fc fusion COVID-19 subunit vaccine, AKS-452. Vaccine. 2022 02 23; 40(9):1253-1260.
    View in: PubMed
    Score: 0.048
  2. Development of an IgG-Fc fusion COVID-19 subunit vaccine, AKS-452. Vaccine. 2021 10 29; 39(45):6601-6613.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.